Zytiga (Janssen Biotech, Inc.)


Welcome to the PulseAid listing for the Zytiga drug offered from Janssen Biotech, Inc.. This Cytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Janssen Biotech, Inc.
NON-PROPRIETARY NAME: abiraterone acetate
SUBSTANCE NAME: ABIRATERONE ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-04-28
END MARKETING DATE: 0000-00-00


Zytiga HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZytiga from Janssen Biotech, Inc.
LABELER NAME: Janssen Biotech, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2011-04-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 57894-150_a7528969-71a7-4264-8424-f456ec43a8bb
PRODUCT NDC: 57894-150
APPLICATION NUMBER: NDA202379

Other ABIRATERONE ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Janssen Biotech, Inc.Zytiga